Insider Selling: Fennec Pharmaceuticals Inc (NASDAQ:FENC) CEO Sells $16,433.56 in Stock

Fennec Pharmaceuticals Inc (NASDAQ:FENC – Get Free Report) CEO Rosty Raykov sold 2,431 shares of the stock in a transaction on Monday, June 3rd. The shares were sold at an average price of $6.76, for a total value of $16,433.56. Following the sale, the chief executive officer now owns 187,471 shares in the company, valued […]

Leave a Reply

Your email address will not be published.

Previous post Insider Buying: Perspective Therapeutics, Inc. (NYSE:CATX) CFO Acquires $35,008.40 in Stock
Next post The London Concours 2023: Grand Tourisme Concours Class